Liver Cancer, Adult Clinical Trial
Official title:
Liver Function Investigation With Single Photon Emission Computed Tomography After Radiotherapy
This is a Phase 1 pilot study to assess feasibility and utility of 99mTc-mebrofenin hepatobiliary scintigraphy for measurement of functional liver change due to radiotherapy.
Patients with cancers of the liver who are not suitable for surgery or chemo/radio embolisation are often treated with stereotactic ablative body radiotherapy (SABR). SABR results in high local control rates but, similar to other treatment modalities, carries risk of damage to healthy surrounding liver. This study aims to use a novel nuclear medicine imaging tracer, 99mTcMebrofenin, to evaluate liver function before and after radiotherapy. Patients will have a 99mTcMebrofenin scan performed < 2 weeks before radiotherapy and 1 and 6 months after radiotherapy. At the same time points, indocyanine green (ICG) and liver elasticity tests will be performed. These are global measures of liver function, whereas 99mTcMebrofenin is both global and local. From the imaging data, the Investigators will be able to correlate change in local liver function in each sub volume of the liver with the radiotherapy dose it received. The Investigators will be able to thus measure the effect of radiotherapy on global and local liver function. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT03674073 -
A Study Combining Personalized Neoantigen-based Dendritic Cell Vaccine With Microwave Ablation for the Treatment of Hepatocellular Carcinoma
|
Phase 1 | |
| Terminated |
NCT02704130 -
TAE and MWA Combination Therapy in Early-stage Hepatocellular Carcinoma
|
N/A | |
| Recruiting |
NCT04864054 -
T-Cell Therapy (ECT204) in Adults With Advanced HCC
|
Phase 2 | |
| Not yet recruiting |
NCT05195294 -
Study of HBV-TCR T Cells (LioCyx-M) as Monotherapy or as Combination With Lenvatinib for HBV-related HCC
|
Phase 1/Phase 2 | |
| Completed |
NCT02191878 -
Safety, Pharmacokinetics and Preliminary Anti-Tumor Activity of Intravenous TKM-080301 in Subjects With Advanced Hepatocellular Carcinoma
|
Phase 1/Phase 2 | |
| Terminated |
NCT00669136 -
Immunization With AFP + GM CSF Plasmid Prime and AFP Adenoviral Vector Boost in Patients With Hepatocellular Carcinoma
|
Phase 1 | |
| Active, not recruiting |
NCT04567615 -
A Study of Relatlimab in Combination With Nivolumab in Participants With Advanced Liver Cancer Who Have Never Been Treated With Immuno-oncology Therapy After Prior Treatment With Tyrosine Kinase Inhibitors
|
Phase 2 | |
| Recruiting |
NCT05705219 -
Development of 3DMPUS as a Decision Support Tool for Patients With Liver Tumors Undergoing Therapy
|
N/A | |
| Terminated |
NCT02527577 -
Analgesia by Transversus Abdominis Plane Nerve Block in Patients Undergoing Liver Resection.
|
N/A |